Skip to main content

Table 1 Resistance patterns of two R. insidiosa isolates

From: Nosocomial bloodstream infection and the emerging carbapenem-resistant pathogen Ralstonia insidiosa

Antibiotics WCHRI065437(μg/mL) WCHRI065162(μg/mL)
Amikacin 64(R) 128(R)
Amoxicillin/Clavulanate 32(R) 32(R)
Ampicillin 32(R) 32(R)
Aztreonam 256(R) 512(R)
Cefepime 2(S) 16(I)
Ceftazidime 8(S) 16(I)
Ceftriaxone 0.5(S) 0.5(S)
Ciprofloxacin < 0.125(S) < 0.125(S)
Gentamicin 32(R) 16(R)
Imipenem 1(S) 8(R)
Levofloxacin 0.125(S) 0.25(S)
Meropenem 1(S) 8(R)
Nitrofurantoin 512(R) 512(R)
Piperacillin/Tazobactam < 4/4(S) < 4/4(S)
Polymyxin B > 512(R) > 512(R)
Tigecycline 0.5(S) 1(S)
Tobramycin 32(R) 32(R)
Trimethoprim/Sulfamethoxazole < 0.25/4.75(S) < 0.25/4.75(S)
  1. R, resistant; S, susceptible; I, intermediate